Table 1.
Characteristics of the study populations
| Characteristics | Number of cases (%) |
|---|---|
| Age (years) | |
| Median | 69 |
| Range | 50–84 |
| BMI (body mass index) (kg/m2) | |
| <24.9 | 120 (19 %) |
| 25–29.9 | 222 (35 %) |
| >30 | 288 (46 %) |
| Number of pregnancies | |
| 1 | 222 (36 %) |
| 2–3 | 408 (64 %) |
| >4 | 0 |
| Use of hormone replacement therapy, HRT | |
| Yes | 432 (69 %) |
| No | 198 (31 %) |
| First menarche | |
| Before 11 years | 80 (12 %) |
| 12–13 years | 320 (51 %) |
| 14–15 years | 170 (27 %) |
| After 16 years | 60 (10 %) |
| FIGO grade | |
| G1 | 180 (29 %) |
| G2 | 420 (67 %) |
| G3 | 30 (5 %) |
| FIGO stage | |
| I | 174 (28 %) |
| II | 441 (70 %) |
| III | 15 (2 %) |
| Menopause status | |
| Postmenopausal | 630 |
| Uterine bleeding | |
| Yes | 450 (71 %) |
| No | 180 (29 %) |
| Endometrial transvaginal ultrasound, TVU | |
| >5 mm | 543 (86 %) |
| Diabetes mellitus | |
| Yes | 186 (30 %) |
| No | 444 (70 %) |
| Hypertension | |
| Yes | 360 (57 %) |
| No | 270 (43 %) |
n = 630